<DOC>
	<DOCNO>NCT03061110</DOCNO>
	<brief_summary>Prospective , single center , double arm , randomize treatment observation ( standard care ) control group . Subjects receive study treatment 6 month study follow-up . Stromal vascular fraction ( SVF ) , adipose-derived tissue preparation , inject salivary gland determine safety efficacy restore saliva production head neck cancer patient chronic xerostomia result radiation therapy .</brief_summary>
	<brief_title>Stromal Vascular Fraction Treatment Xerostomia</brief_title>
	<detailed_description />
	<mesh_term>Xerostomia</mesh_term>
	<criteria>Male Female subject eligible Subjects must 21 year age old History treat Head Neck Cancer , evidence active cancer time study Original tumor locate adjacent parotid submandibular gland Diagnosis radiationinduced xerostomia study fully explain Females child bear potential agree use acceptable method contraception 6 month study followup . No current malignancy history previous malignancy within last five year , head neck cancer , exception adequately treat nonabdominal , nonmelanoma cutaneous carcinoma ( basal cell squamous cell carcinoma skin ) Willing undergo minor surgical procedure ( smallvolume liposuction , total approximately 60120cc ) single treatment injection approximately 30ml autologous Stromal Vascular Fraction take approximately 10 minute Abdominal area amenable liposuction least 60120cc adipose tissue base Investigator ( ) examination Willing available baseline , treatment followup examination require protocol Willing forego participation study throughout duration study unless receive prior approval Investigator Patients take immunosuppressive therapy prior 3 month Autoimmune disorder Patients pregnant currently breastfeed child Patients participate study experimental drug medical device within 60 day study entry Uncontrolled hypertension Reported unstable cardiovascular disease ( e.g. , unstable angina , myocardial infarction within past 6 month , cardiac failure lifethreatening arrhythmia , congestive heart failure ) symptomatic postural hypotension within 6 month screen Hemoglobin A1c &gt; 8 % within 8 week prior study treatment Current use steroid immunosuppressant therapy Any condition , , opinion Investigator , would contraindicate treatment , affect compliance , interfere study evaluation , limit study participation , confound interpretation study result History Sjogren 's Syndrome relate autoimmune disease . Taking medication xerostomia know major side effect</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>